Business Description
Vivozon Pharmaceutical Co Ltd
ISIN : KR7082800004
Compare
Compare
Traded in other countries / regions
082800.Korea IPO Date
2005-11-18Description
Vivozon Pharmaceutical Co Ltd is a global innovative drug development company.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.38 | |||||
| Debt-to-EBITDA | 14.64 | |||||
| Interest Coverage | 2.08 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.67 | |||||
| Beneish M-Score | -2.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.7 | |||||
| 3-Year EPS without NRI Growth Rate | 74 | |||||
| 3-Year Book Growth Rate | -16.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.43 | |||||
| 9-Day RSI | 37.1 | |||||
| 14-Day RSI | 43.94 | |||||
| 6-1 Month Momentum % | 155.83 | |||||
| 12-1 Month Momentum % | 148.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.64 | |||||
| Quick Ratio | 0.37 | |||||
| Cash Ratio | 0.18 | |||||
| Days Inventory | 131.43 | |||||
| Days Sales Outstanding | 47.07 | |||||
| Days Payable | 90.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.8 | |||||
| Shareholder Yield % | 2.51 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.19 | |||||
| Operating Margin % | 4.91 | |||||
| Net Margin % | -3.11 | |||||
| FCF Margin % | -3.94 | |||||
| ROE % | -2.58 | |||||
| ROA % | -1.56 | |||||
| ROIC % | 2.39 | |||||
| ROC (Joel Greenblatt) % | -2.64 | |||||
| ROCE % | -0.75 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.15 | |||||
| PB Ratio | 3.4 | |||||
| Price-to-Tangible-Book | 3.56 | |||||
| Price-to-Operating-Cash-Flow | 51.42 | |||||
| EV-to-EBIT | -439.53 | |||||
| EV-to-EBITDA | 133.48 | |||||
| EV-to-Revenue | 4.15 | |||||
| EV-to-FCF | -125.72 | |||||
| Price-to-Median-PS-Value | 3.24 | |||||
| Earnings Yield (Greenblatt) % | -0.23 | |||||
| FCF Yield % | -1.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vivozon Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 87,275.486 | ||
| EPS (TTM) (â‚©) | -57.913 | ||
| Beta | 0.4 | ||
| Volatility % | 65.37 | ||
| 14-Day RSI | 43.94 | ||
| 14-Day ATR (â‚©) | 1039.777307 | ||
| 20-Day SMA (â‚©) | 8300.5 | ||
| 12-1 Month Momentum % | 148.09 | ||
| 52-Week Range (â‚©) | 2715 - 13600 | ||
| Shares Outstanding (Mil) | 47.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vivozon Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vivozon Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vivozon Pharmaceutical Co Ltd Frequently Asked Questions
What is Vivozon Pharmaceutical Co Ltd(XKRX:082800)'s stock price today?
The current price of XKRX:082800 is â‚©7040.00. The 52 week high of XKRX:082800 is â‚©13600.00 and 52 week low is â‚©2715.00.
When is next earnings date of Vivozon Pharmaceutical Co Ltd(XKRX:082800)?
The next earnings date of Vivozon Pharmaceutical Co Ltd(XKRX:082800) is .
Does Vivozon Pharmaceutical Co Ltd(XKRX:082800) pay dividends? If so, how much?
Vivozon Pharmaceutical Co Ltd(XKRX:082800) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers